US Patent Family Members and Approved Drugs for Russian Federation Patent: 2091087
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Russian Federation Patent: RU2091087
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,626,566 | 2014-05-06 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| 5,626,566 | 2014-05-06 | insulin human | Novo Nordisk Inc. | NOVOLIN R |
| 5,626,566 | 2014-05-06 | somatropin | Novo Nordisk Inc. | NORDITROPIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
